1617 related articles for article (PubMed ID: 6417373)
21. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
22. [Expression of beta 1 integrins in normal B lymphocytes at different stages of development and in B cell neoplasias].
Eichelmann A; Koretz K; Mechtersheimer G; Möller P
Verh Dtsch Ges Pathol; 1992; 76():230-6. PubMed ID: 1283265
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
Aisenberg AC; Wilkes BM
Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
[TBL] [Abstract][Full Text] [Related]
24. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived thereof, also recognizes hairy cell leukemia and some B-cell lymphomas.
Möller P; Mielke B; Moldenhauer G
Am J Pathol; 1990 Mar; 136(3):509-12. PubMed ID: 2316623
[TBL] [Abstract][Full Text] [Related]
26. Two monoclonal antibodies (OKIa1 and OKT10) for the study of the final B cell maturation.
Van Camp B; Thielemans C; Dehou MF; De Mey J; De Waele M
J Clin Immunol; 1982 Jul; 2(3 Suppl):67S-74S. PubMed ID: 6813349
[TBL] [Abstract][Full Text] [Related]
27. Diversity of immunological phenotypes of lymphoblastic lymphoma.
Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
[TBL] [Abstract][Full Text] [Related]
28. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
29. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
30. Chronic lymphoid leukemias: recent advances in biology and therapy.
Foon KA
Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
[TBL] [Abstract][Full Text] [Related]
31. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets.
Forbes IJ; Zalewski PD; Valente L; Gee D
Clin Exp Immunol; 1982 Feb; 47(2):396-404. PubMed ID: 6978783
[TBL] [Abstract][Full Text] [Related]
32. A monoclonal antibody defining a lymphoma-associated antigen in man.
Nadler LM; Stashenko P; Hardy R; Schlossman SF
J Immunol; 1980 Aug; 125(2):570-7. PubMed ID: 6156208
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
[TBL] [Abstract][Full Text] [Related]
34. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
35. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
Mathé G; Belpomme D; Dantchev D; Pouillart P
Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
[TBL] [Abstract][Full Text] [Related]
36. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells.
Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T
Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877
[TBL] [Abstract][Full Text] [Related]
37. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
38. Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia.
Lopez M; De Rossi G; Bonomo G; Napolitano M; Pasqualetti D; Guglielmi C; Annino L; Pandolfi F
Diagn Immunol; 1985; 3(1):11-4. PubMed ID: 3873317
[TBL] [Abstract][Full Text] [Related]
39. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
40. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
